Remab Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2013.
2013 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Remab Pharmaceuticals Private Limited

Remab Pharmaceuticals Private Limited, a active private limited company, was established on 21 February 2013 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24100WB2013PTC190819. Registered under ROC Roc Kolkata I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Atanu Das (Director), Manik Lal Das (Director). It holds ₹2.17 M open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 3/2/F/1, Prafulla Chaki Road, Baranagar,, Kolkata, West Bengal, 700036.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100WB2013PTC190819

  • Registration Number

    190819

  • Incorporation Date

    21 February 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kolkata I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 2 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 2.17 M
  • Revenue Growth **** -3.35%
  • Profit Growth **** 35.75%
  • Ebitda **** -838.09%
  • Net Worth 14.36%
  • Total Assets **** 96.29%
Company report

Remab Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Remab Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Remab Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Atanu Das Director 21 Feb 2013 Current
Manik Lal Das Director 21 Feb 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Remab Pharmaceuticals.

Remab Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.35% decrease. The company also saw a substantial improvement in profitability, with a 35.75% increase in profit. The company's net worth Soared by an impressive increase of 14.36%.

Remab Pharmaceuticals revenue growth over time
Remab Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -3.35%
*******
*******
*******
*******
Revenue from Operations
*******
 -3.35%
*******
*******
*******
*******
Total Assets
*******
 96.29%
*******
*******
*******
*******
Profit or Loss
*******
 35.75%
*******
*******
*******
*******
Net Worth
*******
 14.36%
*******
*******
*******
*******
EBITDA
*******
 -838.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Remab Pharmaceuticals?

In 2019, Remab Pharmaceuticals had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,170,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Bank : 0.22 Cr
Latest Charge Details
Date Lender Amount Status
21 May 2018 Indian Bank ₹2.17 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Remab Pharmaceuticals?

Unlock and access historical data on people associated with Remab Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Remab Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remab Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Remab Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Indian Bank of Rs. 2.17 M registered on 21 May 2018 with Charge ID 100221609 was modified on 12 Jul 2023. was recorded as a recent event.

  • Annual General Meeting

    Progress on Remab Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Remab Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Kolkata I. was documented.

  • Charges

    Progress on A charge with Indian Bank amounted to Rs. 2.17 M with Charge ID 100221609 was registered on 21 May 2018. was documented.

  • Director Appointment

    Atanu Das was appointed as a Director was appointed as a Director on 21 Feb 2013 & has been associated with this company since 13 years 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Manik Lal Das was appointed as a Director was appointed as a Director on 21 Feb 2013 & has been associated with this company since 13 years 2 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Remab Pharmaceuticals Private Limited?

The CIN of Remab Pharmaceuticals Private Limited is U24100WB2013PTC190819.

Where is Remab Pharmaceuticals Private Limited headquartered?

Remab Pharmaceuticals Private Limited is headquartered at 3/2/F/1, Prafulla Chaki Road, Baranagar,, Kolkata, West Bengal, 700036.

When was Remab Pharmaceuticals Private Limited incorporated?

Remab Pharmaceuticals Private Limited was incorporated on 21 February 2013.

Who are the current directors of Remab Pharmaceuticals Private Limited?

The current directors of Remab Pharmaceuticals Private Limited are

What is the primary industry of Remab Pharmaceuticals Private Limited?

The primary industry of Remab Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Remab Pharmaceuticals Private Limited a listed company?

Remab Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Remab Pharmaceuticals Private Limited?

The authorized capital of Remab Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Remab Pharmaceuticals Private Limited?

The compliance status of Remab Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available